3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2/3
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
15
Gastrointestinal
4
Thoracic
3
Plasma cell
3
Lymphoid
3
Head & Neck
3
Sarcoma
2
Other solid neoplasm
2
Genitourinary
2
Tumor-Agnostic
1
Other hematologic neoplasm
1
Gynecologic
1
CNS
1
Conditions
Motor Activity
2
Uterine Cervical Neoplasms
1
Sarcoma
1
Pancreatic Neoplasms
1
Head and Neck Neoplasms
1
Fatigue
1
Esophageal Neoplasms
1
Carcinoma, Bronchogenic
1
Brain Neoplasms
1
Bone Neoplasms
1
Interventions
Radiotherapy
137
Cyclophosphamide
132
Temozolomide
116
Doxorubicin
99
Filgrastim
68
Ifosfamide
64
Gemcitabine
58
Etoposide
55
Bevacizumab
51
Imatinib Mesylate
50
fludarabine phosphate
49
Irinotecan
46
pembrolizumab
45
Peripheral Blood Stem Cell Transplantation
45
pazopanib
43
Magnetic Resonance Spectroscopy
42
Methotrexate
40
Carboplatin
40
Busulfan
40
Vincristine
38
Surgical Procedures, Operative
37
Nivolumab
37
Melphalan
37
Cisplatin
36
Radiation
34
Blood Specimen Collection
33
Mycophenolic Acid
31
Cyclosporine
31
Docetaxel
29
Trabectedin
28
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Exercise Therapy
×
Sarcoma
×
Clear all
NCT04963517
2024-12-06
proGAIT
Universität Duisburg-Essen
Phase 2/3
Completed
11 enrolled
NCT04517019
2020-08-18
OnkoFit II
University Hospital Tuebingen
Phase NA
Unknown
201 enrolled